American drug discovery venture creation firm headquartered in Denver, Colorado and founded in 2019, which builds new biotechnology companies around genetically supported drug targets. Runs a data driven target discovery platform that mines human genetics and other biological data to pick drug creation opportunities, then forms and funds companies around them with a decentralised research model using external scientists, contract research organisations and shared operations rather than its own laboratories.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét